Skip to content
Search

Latest Stories

Bristol Labs director PM Raju succumbs to Covid-19

The co-founder and a senior director of Bristol Laboratories, one of the country’s leading ge­neric medicine manufacturers, died last Sunday (Feb 14) after con­tracting coronavirus.

PM Raju was admitted to the Royal Brompton Hospital in Lon­don last month after his condition deteriorated following the Covid-19 infection.


He succumbed to complica­tions from the virus, having been in the intensive care unit of the hospital for a month. He was 63 and is survived by his wife, Grace, his two sons, Hanson and Benson and his daughter-in-law, Jisha.

Raju helped found Bristol Lab­oratories and played a key role in its meteoric growth over the past decade. He was a close friend and associate of T Ramachandran, the founder and chairman and managing director of the company.

The two friends started the business from a small office in Harrow, North London in 1997 and together built an enterprise spanning the UK and Europe.

RAJU AND RAMACHANDRAN T Ramachandran (L) and PM Raju

Ramachandran said: “I can never forget 40 years of unconditional partnership with him being side by side with me and my family in happiness and sorrow.

“He was a brother to me and my wife Sreedevi and a beloved uncle to my daughters. Words will never do justice for the greatness of one soul who touched the lives of everyone he met.”

Both Raju and Ramachandran formed a close association while working for several years at IPCA Laboratories – a large pharmaceutical company based in India.

In 1997, Raju moved to the UK to help Ramachandran set up Bristol Laboratories and had since been overseeing all aspects of the company’s growth as “second in command”.

In a statement, Bristol Labora­tories said, “His passion, drive and loyalty towards the business was not just a professional one but a personal commitment to serve and excel in the field.

“He was a caring father, a pas­sionate leader and always a phone call away when you need­ed him. He never said no to any­one and has left a void in our hearts forever.”

Raju was a respected and pop­ular member of British pharma industry who did much to push innovation and develop new ter­ritories for Bristol Laboratories.

A regular presence at industry events, he built strong relation­ships with wholesalers and com­munity pharmacists who came to rely on Bristol Laboratories’ ex­tensive product portfolio.

Paying tribute, CEO of Sigma Pharma­ceuticals Bharat Shah said, “I have known Raju for more than 20 years. I have seen him trans­form from an export executive in India with IPCA to becoming a very powerful executive with Bristol Labs in the UK.

“He was instrumental in devel­oping Bristol Laboratories into one of the leading generic medicine manufacturers in the UK. He would help everyone in the most polite and effective manner. He will be greatly missed not only in the ge­nerics industry in the UK, but al­so by people who knew him.”

Born in Adoor, in India's southern state of Kerala, Raju completed his graduation in commerce from Kerala University.

He was the founder and a dedicated member of the Indian Orthodox Church in Hemel Hempstead, serving as the council member of the Diocese of UK-Europe and Africa for several years.

Diocesan Bishop Dr Mathews Mar Thimothios Metropolitan of the Indian Orthodox said: “He always stood as a pillar on my right side for all my missions of the diocese.

PM raju with Bishop PM Raju with bishop outside St Michael's Church in Hamworthy, Pool on Aug 31, 2019

Raju also played an important role in helping to establish a Malayalee Christian community in North London.

A religious leader who knew Raju described how he helped members of the community.

“When people (from Kerala) landed in the UK, whoever got in touch with him would always get plenty of help – anything from finding accommodation to finding a job. This has been the case for many years,” he said.

The secretary of the Hemel Hempstead church praised Raju as a “very hard working, soft spoken person and a great role model to everyone”.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less